Photocure
1 investor is following this company
Photocure is a medical technology company. The company specializes in solutions for photodynamic technology. The solutions are used to treat diseases that have caused bladder cancer and HPV. The main markets are in dermatology and oncology, where the products are used by hospitals and research institutes on a global level. The company was founded in 1993 and is headquartered in Oslo, Norway.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Oslo Børs
PHO
Daily low / high price
-
Market cap
-
Turnover
-
Volume
-
Financial calendar
Interim report
07.08.2024
Interim report
13.11.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Morgan Stanley & Co. LLC | 15.5 % | 15.5 % |
SEB | 7.2 % | 7.2 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization
PHO: Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools